尔康制药维生素B6注射液通过仿制药一致性评价

Core Viewpoint - Erkang Pharmaceutical has received approval from the National Medical Products Administration for its Vitamin B6 injection, which has passed the consistency evaluation of quality and efficacy for generic drugs, enhancing its market competitiveness and potential for sales growth [1] Group 1: Product Approval - The company announced that its Vitamin B6 injection (1ml:100mg) has been approved, which is primarily used for the prevention and treatment of Vitamin B6 deficiency and related conditions [1] - The approval is expected to positively impact the market expansion and sales of the related products [1] Group 2: Market Reaction - Following the announcement, Erkang Pharmaceutical's stock price increased by 7.17%, closing at 3.44 yuan per share [1]